Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of …
JD Brunzell, M Davidson, CD Furberg… - Journal of the American …, 2008 - jacc.org
Risk factors for type 2 diabetes and cardiovascular disease (CVD) often cluster, including
obesity (particularly central), insulin resistance, hyperglycemia, dyslipoproteinemia, and …
obesity (particularly central), insulin resistance, hyperglycemia, dyslipoproteinemia, and …
Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges
UK Sampson, S Fazio, MRF Linton - Current atherosclerosis reports, 2012 - Springer
This review captures the existence, cause, and treatment challenges of residual
cardiovascular risk (CVR) after aggressive low-density lipoprotein cholesterol (LDL-C) …
cardiovascular risk (CVR) after aggressive low-density lipoprotein cholesterol (LDL-C) …
[HTML][HTML] Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized …
SJ Athinarayanan, RN Adams, SJ Hallberg… - Frontiers in …, 2019 - frontiersin.org
Purpose: Studies on long-term sustainability of low-carbohydrate approaches to treat
diabetes are limited. We previously reported the effectiveness of a novel digitally-monitored …
diabetes are limited. We previously reported the effectiveness of a novel digitally-monitored …
Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study
OBJECTIVE Type 2 diabetes (T2D) is a public health threat. Prediabetes represents a
window of opportunity for intervention to prevent T2D. Men with T2D and prediabetes often …
window of opportunity for intervention to prevent T2D. Men with T2D and prediabetes often …
Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose
RA DeFronzo, M Abdul-Ghani - The American journal of cardiology, 2011 - Elsevier
Individuals with impaired glucose tolerance (IGT) and/or impaired fasting glucose (IFG) are
at high risk, not only to develop diabetes mellitus, but also to experience an adverse …
at high risk, not only to develop diabetes mellitus, but also to experience an adverse …
The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy–a review of the evidence
G Walldius, I Jungner - Journal of internal medicine, 2006 - Wiley Online Library
During the last several years interest has focused on the importance of the lipid‐transporting
apolipoproteins–apoB transports all potentially atherogenic very low‐density lipoprotein …
apolipoproteins–apoB transports all potentially atherogenic very low‐density lipoprotein …
Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus
C Moroti, LF Souza Magri, M de Rezende Costa… - Lipids in health and …, 2012 - Springer
Background The consumption of foods containing probiotic and prebiotic ingredients is
growing consistently every year, and in view of the limited number of studies investigating …
growing consistently every year, and in view of the limited number of studies investigating …
[HTML][HTML] Current data regarding the relationship between type 2 diabetes mellitus and cardiovascular risk factors
Reducing cardiovascular risk (CVR) is the main focus of diabetes mellitus (DM)
management nowadays. Complex pathogenic mechanisms that are the subject of this …
management nowadays. Complex pathogenic mechanisms that are the subject of this …
Non–high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease
J Liu, CT Sempos, RP Donahue, J Dorn… - The American journal of …, 2006 - Elsevier
To determine if non–high-density lipoprotein (HDL) cholesterol is a more useful predictor of
coronary heart disease (CHD) risk than low-density lipoprotein (LDL) cholesterol and if very …
coronary heart disease (CHD) risk than low-density lipoprotein (LDL) cholesterol and if very …
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline
JL Rosenzweig, E Ferrannini, SM Grundy… - The Journal of …, 2008 - academic.oup.com
Objective: The objective was to develop clinical practice guidelines for the primary
prevention of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) in patients …
prevention of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) in patients …